Skip to main content

Table 2 A comparison of changes in AD symptoms between baseline and week 4 and periodic analysis of AD symptoms

From: Effect of acupuncture treatment in patients with mild to moderate atopic dermatitis: a randomized, participant- and assessor-blind sham-controlled trial

Variables

Verum Acupuncture (n = 18)

Sham Acupuncture (n = 17)

Difference between groups after adjusted baseline value (95% CI)

P valuea

Total SCORADb

 LS mean (SE) at baseline

34.38 (2.30)

34.90 (2.37)

 LS mean (SE) at week 2

27.25 (2.60)

35.12 (2.67)

7.37 (3.46, 11.29)

0.0036

 LS mean (SE) at week 4

22.55 (2.83)

35.35 (2.91)

12.31 (7.14, 17.48)

<.0001

 LS mean (SE) After treatment, at week 8

21.50 (2.97)

34.06 (3.06)

12.06 (6.36, 17.77)

0.0006

Objective SCORADb

 LS mean (SE) at baseline

24.90 (2.02)

25.53 (2.08)

 LS mean (SE) at week 2

20.22 (2.20)

26.50 (2.27)

5.66 (3.02, 8.29)

0.0006

 LS mean (SE) at week 4

16.90 (2.27)

27.45 (2.34)

9.94 (6.64, 13.25)

<.0001

 LS mean (SE) After treatment, at week 8

15.94 (2.34)

26.62 (2.40)

10.12 (5.82, 14.42)

<.0001

EASIb

 LS mean (SE) at baseline

5.16 (1.16)

5.83 (1.19)

 LS mean (SE) at week 2

4.47 (1.26)

5.97 (1.29)

0.78 (0.02, 1.55)

0.2754

 LS mean (SE) at week 4

3.44 (1.22)

6.49 (1.26)

2.40 (0.99, 3.81)

0.0090

 LS mean (SE) After treatment, at week 8

3.29 (1.29)

6.13 (1.33)

2.15 (0.74, 3.57)

0.0246

POEM

 LS mean (SE) at baseline

12.39 (1.26)

14.18 (1.29)

 LS mean (SE) at week 2

9.44 (1.46)

12.35 (1.51)

1.36(−1.48, 4.20)

> 0.9999

 LS mean (SE) at week 4

7.72 (1.53)

11.65 (1.57)

2.37(−0.73, 5.48)

0.7758

 LS mean (SE) After treatment, at week 8

7.78 (1.70)

11.76 (1.75)

2.02(− 0.82, 4.85)

0.9432

DLQI

 LS mean (SE) at baseline

8.83 (1.34)

10.24 (1.38)

 LS mean (SE) at week 2

6.28 (1.00)

6.76 (1.02)

−0.26(−2.25, 1.72)

> 0.9999

 LS mean (SE) at week 4

5.06 (0.95)

5.76 (0.98)

0.23(−2.18, 2.64)

> 0.9999

 LS mean (SE) After treatment, at week 8

4.72 (1.03)

5.47 (1.06)

0.10(−2.27, 2.48)

> 0.9999

  1. Abbreviations: SCORAD Scoring Atopic Dermatitis (range, 0 [clear] to 100 [very severe]), EASI Eczema Area and Severity Index, POEM Patient-Oriented Eczema Measure (range, 0 [clear] to 28 [very severe]), DLQI Dermatology Life Quality Index (range. 0 [no effect of skin disease on quality of life] to 30 [maximum effect on quality of life])
  2. a From an analysis of covariance (ANCOVA) with a factor of treatment group and corresponding baseline value as the covariate. The p-value is corrected by multiple comparisons
  3. b This shows a significant difference between groups through repeated measures ANOVA (RM ANOVA). In addition, the LS mean is the least squares mean estimated by RM ANOVA